Skip to main content
. 2018 Oct 3;2(19):2513–2521. doi: 10.1182/bloodadvances.2017010744

Figure 5.

Figure 5.

Overlapping mutations are significantly enriched in MDS and AML-MRC. Each dot represents the number of overlapping mutations (A) and overlapping mutations except for DNMT3A, TET2, and ASXL1 (B) in each patient. Asterisks indicate the number of mutations detected in NPM1-AML. *P < .05, **P < .01. NS, not significant.